First Horizon Advisors’s BeOne Medicines Ltd ONC Stock Holding History

First Horizon Advisors’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-21	Closed	-$3K	–	2495
2022 Q2	$3K	Buy	21 +2	+11%	+$312	﹤0.01%	2026
2022 Q1	$4K	Sell	19 -88	-82%	-$18.7K	﹤0.01%	1359
2021 Q4	$28K	Sell	107 -22	-17%	-$7.43K	﹤0.01%	1163
2021 Q3	$46K	Hold	129	–	–	﹤0.01%	937
2021 Q2	$44K	Hold	129	–	–	﹤0.01%	839
2021 Q1	$44K	Hold	129	–	–	﹤0.01%	791
2020 Q4	$33K	Hold	129	–	–	﹤0.01%	739
2020 Q3	$36K	Hold	129	–	–	﹤0.01%	642
2020 Q2	$23K	Hold	129	–	–	﹤0.01%	758
2020 Q1	$15K	Hold	129	–	–	﹤0.01%	844
2019 Q4	$20K	Hold	129	–	–	﹤0.01%	867
2019 Q3	$15K	Hold	129	–	–	﹤0.01%	955
2019 Q2	$15K	Hold	129	–	–	﹤0.01%	963
2019 Q1	$16K	Hold	129	–	–	﹤0.01%	910
2018 Q4	$17K	Hold	129	–	–	﹤0.01%	862
2018 Q3	$21K	Buy	+129	New	+$21.7K	﹤0.01%	871

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

First Horizon Advisors's ONC Position: Q3 2022 in Review

First Horizon Advisors sold out of BeOne Medicines Ltd (ONC) in Q3 2022, closing a stake of 21 shares — an estimated $3K sold.

First Horizon Advisors first reported a position in ONC in Q3 2018 and held it in 16 quarters. The position peaked at $46K in Q3 2021. 223 funds tracked by Wall St. Rank hold ONC as of Q3 2022.

First Horizon Advisors reported no remaining BeOne Medicines Ltd position as of Q3 2022 after selling out during the quarter.
First Horizon Advisors sold 21 BeOne Medicines Ltd shares in Q3 2022, an estimated $3K.
First Horizon Advisors first reported a position in BeOne Medicines Ltd in Q3 2018 and held it in 16 quarters.
First Horizon Advisors's BeOne Medicines Ltd position peaked at $46K in Q3 2021.
223 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2022.

Based on First Horizon Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.